← Leaderboards
Robert Brakaj
Ccs Associates, Inc.
$156,415
Attributed
$156,415
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $105.9K · FY2023–24$200K$150K$100K$50K$0
'23
'24
Funding mix
By agency
NIH$156,415 · 2
By mechanism
N01$105,871 · 1
N02$50,544 · 1
Top collaborators
No co-investigators on record.
Most similar at Ccs Associates, Inc.
Same institution · by research overlap
- Karen Hansen$3,146,709
- Caroline C Sigman$32,114,409
- Linda Doody$342,493
- Caroline Sigman$38,271,961
Others in their field
Other Rising Stars on “Clinical Trials”
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Angee Greer · Ppd Development Lp$82,531,927
- Jessica Ellis · Technical Resources International, Inc.$46,538,640
- Jessica Holden · Technical Resources International, Inc.$37,843,443
- Suma Babu · Massachusetts General Hospital$36,168,406
- Sabrina Paganoni · Massachusetts General Hospital$36,168,406
Research focus
Clinical TrialsBoneChronic Kidney FailureClinical ApplicationClinical ResearchCommunicable DiseasesContractsCranial NervesCraniumDeformityDialysis ProcedureEffective TherapyEpiphysial CartilageEquilibriumGood Clinical PracticeHearing ImpairmentHormone ReceptorInvestigational New Drug ApplicationIonsKidneyKidney TransplantationLeadLifeMetaphyseal Chondrodysplasia
Grant awards (2)
Vendor Audit Support Through the Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) Contract$105,871
N01 · FY2024 · AI · contact PI
PREPARATION OF AN INVESTIGATIONAL NEW DRUG (IND) APPLICATION WITH FOOD AND DRUG ADMINISTRATION (FDA) FOR A TREATMENT FOR JANSEN'S METAPHYSEAL CHONDRODYSPLASIA$50,544
N02 · FY2023 · DA · contact PI